| Home | E-Submission | Sitemap | Editorial Office |  
top_img
        
REVIEW ARTICLE 2022 June 21
An overview of radiation-induced heart disease
Radiation therapy (RT) has dramatically improved cancer survival, leading to several inevitable complications. Unintentional irradiation of the heart can lead to radiation-induced heart disease (RIHD), including cardiomyopathy, pericarditis, coronary artery disease, valvular hea...
ORIGINAL ARTICLE 2022 May 25
Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
Purpose: This study aims to assess the locoregional efficacy of postoperative vaginal brachytherapy (VBT) alone in patients undergoing surgical staging for early-stage high-intermediate-risk (HIR) and high-risk (HR) endometrial cancer. Materials and Methods: One hundred and fo...
ORIGINAL ARTICLE 2022 May 20
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Purpose: To investigate the role of pre- and post-stereotactic body radiation therapy (SBRT) neutrophil-to-lymphocyte ratio (NLR) in patients with localized pancreatic cancer treated with anti-PD-1 (programmed cell death protein-1) antibody and SBRT. Materials and Methods: This...
ORIGINAL ARTICLE 2022 May 17
Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Purpose: The purpose of this study was to evaluate the treatment outcomes and toxicity profile of patients with early glottic cancer who underwent hypofractionated radiation therapy (RT) with 3.5 Gy per fraction. Materials and Methods: A retrospective review was performed of th...
ORIGINAL ARTICLE 2022 June 20
Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Purpose: To assess the feasibility of accelerated hypofractionated radiotherapy with simultaneous integrated boost (SIB) in patients with breast cancer. Materials and Methods: A total of 27 patients after breast-conserving surgery were included in this study. Patients were plan...
ORIGINAL ARTICLE 2022 May 20
Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Purpose: For patients with early breast cancer who undergo breast-conserving surgery, adjuvant whole breast irradiation (WBI) with simultaneous integrated boost (SIB) results in lower radiotherapy fractions. Published studies have shown that both conventional fraction with SIB (...
ORIGINAL ARTICLE 2022 June 20
Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Purpose: Conventionally fractionated radiotherapy (CRT) is widely applied for the treatment of high-risk prostate cancer. Pelvic node irradiation improves control of the disease. Although the therapeutic guidelines support the use of hypofractionated and accelerated radiotherapy...
CASE REPORT 2022 May 20
Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Erdheim-Chester disease (ECD) is a rare non-Langerhans cell histiocytosis typically featuring lower extremity osteosclerosis (96%) from Langerin-negative histiocytes with fibrosis. Central nervous system (CNS)-only disease is extremely rare, and particularly difficult to diagnos...

If anyone registers his/her email address, he or she will receive the email of notification when new paper is published in the web site of Radiation Oncology Journal. Since it is open access journal, the full text is freely available.
Please Sign up.
Current Issue
Volume 40(2); June 2022
RSS feed
Review Article
89 An overview of radiation-induced heart disease
Samer Ellahham, Amani Khalouf, Mohammed Elkhazendar, Nour Dababo, Yosef Manla
Radiat Oncol J. 2022;40(2):89-102.   Published online 2022 Jun 21     DOI: https://doi.org/10.3857/roj.2021.00766
                              
roj-2021-00766f1.jpgroj-2021-00766f2.jpgroj-2021-00766f3.jpg
Original Articles
Clinical Investigations
103 Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy
Candan Demiroz Abakay, Sonay Arslan, Meral Kurt, Sibel Cetintas
Radiat Oncol J. 2022;40(2):103-110.   Published online 2022 May 25     DOI: https://doi.org/10.3857/roj.2021.00864
                              
t2-roj-2021-00864.png
111 Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy
Abhinav V. Reddy, Colin S. Hill, Shuchi Sehgal, Lei Zheng, Jin He, Daniel A. Laheru, Ana De Jesus-Acosta, Joseph M. Herman, Jeffrey Meyer, Amol K. Narang
Radiat Oncol J. 2022;40(2):111-119.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01060
                              Supplementary      
roj-2021-01060f1.jpgroj-2021-01060f2.jpgt2-roj-2021-01060.png
120 Hypofractionated radiotherapy for early stage glottic cancer: efficacy of 3.5 Gy per fraction
Tae Hoon Lee, Joo Ho Lee, Seong Keun Kwon, Eun-Jae Chung, Hong-Gyun Wu
Radiat Oncol J. 2022;40(2):120-126.   Published online 2022 May 17     DOI: https://doi.org/10.3857/roj.2021.01025
                              
roj-2021-01025f1.jpgroj-2021-01025f2.jpgt2-roj-2021-01025.png
127 Accelerated hypofractionated breast radiotherapy with simultaneous integrated boost: a feasibility study
Budhi Singh Yadav, Shipra Gupta, Divya Dahiya, Ankita Gupta, Arun Singh Oinam
Radiat Oncol J. 2022;40(2):127-140.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01053
                              
roj-2021-01053f1.jpgroj-2021-01053f2.jpgroj-2021-01053f3.jpgroj-2021-01053f4.jpg
141 Long-term oncological outcomes of hypofractionated versus conventional fractionated whole breast irradiation with simultaneous integrated boost in early-stage breast cancer
Chawalit Lertbutsayanukul, Manida Pitak, Chonnipa Nantavithya
Radiat Oncol J. 2022;40(2):141-150.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.00927
                              Supplementary      
roj-2021-00927f1.jpgroj-2021-00927f2.jpg
151 Radiobiological analysis of preliminary results of a phase II study of pelvic hypofractionated and accelerated radiotherapy for high-risk prostate cancer patients
Christos Nanos, Vasilios Souftas, Athanasios Zissimopoulos, Michael I. Koukourakis
Radiat Oncol J. 2022;40(2):151-161.   Published online 2022 Jun 20     DOI: https://doi.org/10.3857/roj.2021.01032
                              
roj-2021-01032f1.jpgroj-2021-01032f2.jpgroj-2021-01032f3.jpg
Case Report
162 Craniospinal irradiation for respiratory failure secondary to central nervous system Erdheim-Chester disease
Rahul N. Prasad, Peter J. Kobalka, Haley K. Perlow, Daniel M. Prevedello, Dukagjin M. Blakaj, Raju R. Raval, Joshua D. Palmer
Radiat Oncol J. 2022;40(2):162-168.   Published online 2022 May 20     DOI: https://doi.org/10.3857/roj.2021.01074
                              
roj-2021-01074f1.jpgroj-2021-01074f2.jpgroj-2021-01074f3.jpgroj-2021-01074f4.jpg
E-Submission
Principles of Transparency and Best Practice
Author's Index
KOSRO
SCImago Journal & Country Rank
PubMed Central
PubMed
Scopus
KoreaMed
KoMCI
ScienceCentral
GoogleScholar
Similarity Check
Crossref Cited-by Linking
CrossMark
Funder Registry
Metadata
ORCID
COPE
HDX Corporation
Elekta Korea
Editorial Office
Department of Radiation Oncology, Seoul National University Hospital,
Hamchun Hall, 6F, 95 Daehak-ro, Jongno-gu, Seoul 03082, Republic of Korea
Tel : +82-2-743-6574
E-mail: roj@kosro.or.kr
Copyright © The Korean Society for Radiation Oncology.                      Developed in M2PI
Close layer
prev next